Cargando…

Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer

Background: It has been reported that thymidine kinase 1 (TK1) was up-regulated in multiple malignancies and participated in the regulation of tumor malignant behavior. However, its specific role in prostate cancer (PCa) remains unclear. Methods: TK1 expression in PCa patients and cell lines was ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Hui, Guo, Linpei, Wang, Zhun, Peng, Shuanghe, Ma, Qianwang, Yang, Zhao, Shang, Zhiqun, Niu, Yuanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086852/ https://www.ncbi.nlm.nih.gov/pubmed/35559045 http://dx.doi.org/10.3389/fgene.2022.778850

Ejemplares similares

YAP is required for prostate development, regeneration, and prostate stem cell function
por: Xie, Hui, et al.
Publicado: (2023)

Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018)

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer
por: Guo, Linpei, et al.
Publicado: (2021)

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals
por: Wang, Zhun, et al.
Publicado: (2017)

Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2017)

Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018)

Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
por: Chen, Xuanrong, et al.
Publicado: (2020)

Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer
por: Chen, Xuanrong, et al.
Publicado: (2021)

A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy
por: Chen, Xuanrong, et al.
Publicado: (2021)

Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma
por: Gao, Yukui, et al.
Publicado: (2022)

Methylation status of TK1 correlated with immune infiltrates in prostate cancer
por: Zhang, Chenming, et al.
Publicado: (2022)

Increased KIF4A expression is a potential prognostic factor in prostate cancer
por: Gao, Hongwei, et al.
Publicado: (2018)

Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3
por: Chen, Xuanrong, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients
por: Zhang, Zheng, et al.
Publicado: (2018)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker
por: Wang, Rui, et al.
Publicado: (2023)

FISH comets show that the salvage enzyme TK1 contributes to gene-specific DNA repair
por: McAllister, Katherine A., et al.
Publicado: (2014)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
por: Eid, Refaat A., et al.
Publicado: (2023)

Development and validation of CT imaging–based preoperative nomogram in the prediction of unfavorable high-grade small renal masses
por: Xie, Hui, et al.
Publicado: (2019)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

Post-transcriptional modification of m(6)A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer
por: Li, Yang, et al.
Publicado: (2023)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma
por: Li, Xiangpan, et al.
Publicado: (2022)

A systematic analysis of C5ORF46 in gastrointestinal tumors as a potential prognostic and immunological biomarker
por: Jiang, Yuhong, et al.
Publicado: (2022)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
por: Tian, Jun, et al.
Publicado: (2021)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Systematic analysis of prognostic and immunologic characteristics associated with coronavirus disease 2019 regulators in acute myeloid leukemia
por: Shi, Mingjie, et al.
Publicado: (2022)

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022)

Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma
por: Bai, Zhiqun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fqcsacfkm3f600ov010v9kc1kj